Cargando…
Genetic Deficiency of Glycogen Synthase Kinase-3β Corrects Diabetes in Mouse Models of Insulin Resistance
Despite treatment with agents that enhance β-cell function and insulin action, reduction in β-cell mass is relentless in patients with insulin resistance and type 2 diabetes mellitus. Insulin resistance is characterized by impaired signaling through the insulin/insulin receptor/insulin receptor subs...
Autores principales: | Tanabe, Katsuya, Liu, Zhonghao, Patel, Satish, Doble, Bradley W, Li, Lin, Cras-Méneur, Corentin, Martinez, Sara C, Welling, Cris M, White, Morris F, Bernal-Mizrachi, Ernesto, Woodgett, James R, Permutt, M. Alan |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2245985/ https://www.ncbi.nlm.nih.gov/pubmed/18288891 http://dx.doi.org/10.1371/journal.pbio.0060037 |
Ejemplares similares
-
Glucose and Fatty Acids Synergize to Promote B-Cell Apoptosis through Activation of Glycogen Synthase Kinase 3β Independent of JNK Activation
por: Tanabe, Katsuya, et al.
Publicado: (2011) -
Transgenic Overexpression of Active Calcineurin in β-Cells Results in Decreased β-Cell Mass and Hyperglycemia
por: Bernal-Mizrachi, Ernesto, et al.
Publicado: (2010) -
Role of nutrients and mTOR signaling in the regulation of pancreatic progenitors development
por: Elghazi, Lynda, et al.
Publicado: (2017) -
Early pancreatic islet fate and maturation is controlled through RBP-Jκ
por: Cras-Méneur, Corentin, et al.
Publicado: (2016) -
Glycogen synthase kinase 3, circadian rhythms, and bipolar disorder: a molecular link in the therapeutic action of lithium
por: Kaladchibachi, Sevag A, et al.
Publicado: (2007)